TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Drugmaker Eli Lilly's Q4 Profits Slide on Back of Stronger Dollar
Play
INVESTING

Eli Lilly Shares Climb; Morgan Stanley Upgrades Drugmaker to Overweight and Lifts Price Target

PRESS RELEASES

FDA Approves Saxenda® For The Treatment Of Obesity In Adolescents Aged 12-17

PRESS RELEASES

EMISPHERE INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Emisphere Technologies, Inc. - EMIS

PRESS RELEASES

EMISPHERE INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Emisphere Technologies, Inc. - EMIS

PRESS RELEASES

(EMIS) Alert: Johnson Fistel Investigates Proposed Sale Of Emisphere; Are Shareholders Getting A Fair Deal?

PRESS RELEASES

IIROC Trading Resumption - NVO

PRESS RELEASES

IIROC Trading Halt - NVO

PRESS RELEASES

Novo To Present At The OTCQX Resource Company Virtual Investor Conference

PRESS RELEASES

Novo Nordisk Offers Free 90-day Insulin Supply To People Experiencing Financial Hardship Due To COVID-19

PRESS RELEASES

Coronavirus (COVID-19) Resources Available From Novo Nordisk In The US

Drugmaker Eli Lilly's Q4 Profits Slide on Back of Stronger Dollar
INVESTING

Eli Lilly Shares Climb; Morgan Stanley Upgrades Drugmaker to Overweight and Lifts Price Target

Abiomed Shares Take Beating After Studies Question Heart Pump
MARKETS

UniQure Jumps on Report It's Exploring a Possible Sale

Gilead Sciences Names Roche's O'Day as CEO and Chairman
INVESTING

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Technology Isn't a Choice: Cramer's 'Mad Money' Recap (Wednesday 11/20/19)
JIM CRAMER

Downgrades Are Important: Cramer's 'Mad Money' Recap

Ollie's Bargain Outlet Slumps After Chairman and CEO Butler Dies at 61
JIM CRAMER

Ollie's Bargain Outlet, Novo Nordisk, Avnet: 'Mad Money' Lightning Round

Global Stocks March Higher as Upbeat Powell, Robust Earnings Ignite the Bulls
MARKETS

Stocks Mixed as Asia Gets China Trade Boost, Wall Street Rides Earnings Wave

Drug Pricing Turns to Insulin as Politicians, AMA and Docs Look to Pharma
POLITICS

Drug Pricing Turns to Insulin As Politicians, AMA And Docs Look to Pharma

Drug Pricing Turns to Insulin as Politicians, AMA and Docs Look to Pharma
INVESTING

Novo Nordisk Stock Rises 4% Over 2 Sessions

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results
STOCKS

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results

Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns
MARKETS

Eli Lilly's Trulicity benefits from growth of diabetes drugs

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices
REGULATION

Why investors shouldn't worry about Trump's tough talk on drug prices

Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns
STOCKS

Eli Lilly beats estimates, but shares head lower amid diabetes concerns

Sanofi Strikes $11.6 Billion Deal for Bioverativ
STOCKS

Sanofi announces second billion-dollar deal in a week, and it may not be done

Dow Braces for Second Triple-Digit Decline as Global Stocks Retreat
FUTURES

5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know Before the Market Opens

Novo Nordisk Hits 2017 High After Q1 Profit Beat, Full-Year Guidance Boost
MARKETS

Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade